Voyager Therapeutics GAAP EPS of -$0.40 beats by $0.02, revenue of $4.01M misses by $2.34M

Voyager Therapeutics Q3 earnings: EPS beat, revenue missed, and cash runway extends into Q2 2028.

CryptoAlerta — análise de criptomoedas e mercado em tempo real